CAS 56961-10-5

SARS-CoV-2-IN-13

CAS: 56961-10-5

SARS-CoV-2-IN-13

Reinheit: ≥98%

Molekulargewicht: 327.12g/mol

Ref: 54-BUP08581

SARS-CoV-2-IN-13

CAS: 56961-10-5

SARS-CoV-2-IN-13, a stable niclosamide analogue, enhances oral bioavailability and inhibits SARS-CoV-2 (IC50: 0.057 μM).

Formel: C₁₃H₈Cl₂N₂O₄

Reinheit: 98.54%

Farbe und Form: Solid

Molekulargewicht: 327.12

Ref: TM-T60919